A quieter side of schizophrenia
When people hear "schizophrenia," they often think of hallucinations or delusions. Those are called positive symptoms.
But there's another set of symptoms that's harder to see and much harder to treat. Doctors call them negative symptoms.
Negative symptoms include low motivation, flat emotions, social withdrawal, and feeling unable to enjoy anything. About 1 in 4 people with schizophrenia struggle with them long-term.
Current medicines work fairly well for hallucinations. But they barely move the needle on negative symptoms. That's a huge gap in care.
The old story, and the twist
For years, experts mostly blamed biology. Brain chemistry. Genetics. Damaged reward pathways.
But here's the twist. Researchers are now asking whether the world around a person, not just the brain inside, might shape these symptoms too.
This study is one of the first to test that idea in a very specific way. It looked at racial discrimination, a daily source of stress for many Black Americans, and whether it could feed negative symptoms.
The "inner critic" at the center
To understand the study, picture your mind as a car dashboard.
Defeatist performance beliefs, or DPB, are like a warning light that never turns off. It keeps flashing, "You won't succeed. Don't even try."
When that light is stuck on, you stop driving. You stop calling friends. You stop going to work. Not because you don't want to, but because your own brain keeps telling you it's pointless.
Researchers suspected that repeated experiences of racism might be turning that warning light on and keeping it on.
The team studied 208 adults diagnosed with schizophrenia-spectrum disorders. Of those, 80 were Black and 128 were White.
Each person filled out standard surveys. Some measured negative symptoms. Others measured defeatist beliefs. Others asked about real-life experiences of racial and ethnic discrimination.
Then the researchers used statistics to see how these things connected.
Black participants had significantly more negative symptoms than White participants. That part lines up with what earlier research has shown.
But the interesting finding was why.
Racial discrimination explained 46% of the gap in negative symptoms between Black and White participants. Nearly half.
This doesn't mean race causes negative symptoms. It means the stress of being treated unfairly because of race appears to.
Among Black participants, people who reported more discrimination also held stronger defeatist beliefs. And those stronger "I'll fail" beliefs were tied to worse negative symptoms.
In plain English: discrimination seems to feed the inner critic, and the inner critic seems to feed the withdrawal.
But there's a catch
This is where things get interesting. Defeatist beliefs only partly explained the link. So discrimination may be harming people through several paths, not just one.
That could include chronic stress on the body, sleep problems, trauma responses, or broken trust in doctors and systems.
Where this fits in the bigger picture
For decades, schizophrenia care has focused almost entirely on what's happening inside the brain.
This research adds to a growing view that social environment matters, too. It doesn't replace biology. It joins it.
If discrimination can push symptoms up, then therapies that help people process and push back against those experiences might actually ease symptoms. That's a different way of thinking about treatment.
If you or someone you love has schizophrenia and feels stuck in low motivation or hopelessness, this study offers one quiet piece of good news.
Those feelings may not be purely "chemical." They may respond to therapy that addresses self-critical thoughts and the real stressors fueling them.
Talk to a mental health provider about cognitive therapies that target defeatist beliefs. For Black patients, ask whether culturally informed therapy is available. That kind of care takes racism seriously as a health issue, not just a social one.
None of this replaces medication. But it may add a missing piece.
Honest limits
This was a single study with 208 people. That's modest in size.
It relied on self-report surveys, which can be influenced by mood and memory. It also can't prove cause and effect. It can only show strong patterns worth investigating further.
Larger studies, with more diverse groups and longer follow-up, are needed before clinics change how they treat negative symptoms.
Researchers now want to test whether therapies built around these findings actually help. That means designing treatments that address defeatist thinking and the racial stress feeding it, then measuring whether negative symptoms ease.
It will take years of work. Clinical trials move slowly because patient safety comes first, and mental health treatments need careful testing before they reach everyday care.
But for the first time, there's a clear target. And a clearer map of how the outside world may be shaping a deeply misunderstood part of schizophrenia.